journal article·2016-03

Synthesis of a 4-nitroimidazole indocyanine dye-conjugate and imaging of tumor hypoxia in BALB/c tumor-bearing female mice

Akram Abuteen, Feifei Zhou, Christopher Dietz, Innus Mohammad, Michael B. Smith, Quing Zhu

Dyes and Pigments· Volume 126
Publisher page

Abstract

Abstract Extending our previous work with 2-nitroimidazole-indocyanine dye-conjugate 4 , we prepared the 4-nitroimidazole-piperazine-indocyanine derivative ( 6 ). We also prepared imidazole derivative 5 as a control. We compared the in vivo hypoxia targeting performance of both 5 and 6 with the previously tested 4 , and 6 showed a higher fluorescent intensity after 15 min post-injection, about 1.5-fold higher than 4 and 2.5-fold higher than 5 . Cells treated with 6 under hypoxic conditions showed a higher fluorescence yield when compared to the cells kept under normoxic conditions. All findings were supported with fluorescence images of histological sections of tumor samples using a Li-COR scanner and an immunohistochemistry technique for tumor hypoxia.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. The hallmarks of cancer10.1016/S0092-8674(00)81683-9 ↗
2. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review
3. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy
4. The histological structure of some human lung cancers and the possible implications for radiotherapy10.1038/bjc.1955.55 ↗
5. Nitroimidazoles and imaging hypoxia10.1007/BF01081524 ↗
6. Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia10.1016/j.nucmedbio.2012.11.003 ↗
7. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
8. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects10.1093/jnci/93.4.266 ↗
9. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
10. A review of indocyanine green fluorescent imaging in surgery10.1155/2012/940585 ↗
11. Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo10.1038/ncomms6834 ↗
12. Molecular imaging of hypoxia10.2967/jnumed.110.075663 ↗
13. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green10.1158/0008-5472.CAN-08-3116 ↗
14. Novel fluorophores as building blocks for optical probes for in vivo near infrared fluorescence (NIRF) imaging10.1007/s10895-010-0603-7 ↗
15. Molecular imaging in cancer10.1126/science.1125949 ↗
16. In vivo pathology: seeing with molecular specificity and cellular resolution in the living body10.1146/annurev.pathol.2.010506.091930 ↗
17. In vitro testing of a protease-sensitive contrast agent for optoacoustic imaging10.1117/1.3365935 ↗
18. In vivo near-infrared fluorescence imaging10.1016/j.cbpa.2003.08.007 ↗
19. Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis10.1016/j.biomaterials.2014.05.073 ↗
20. Evaluation of polymethine dyes as potential probes for near infrared fluorescence imaging of tumors: part 110.7150/thno.5922 ↗
21. Gold nanocage-photosensitizer conjugates for dual-modal image-guided enhanced photodynamic therapy10.7150/thno.7064 ↗
22. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents10.1038/sj.neo.7900118 ↗
23. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement10.1073/pnas.040570597 ↗
24. in vivo fluorescence microscopy of neuronal activity in three dimensions by use of voltage-sensitive dyes10.1364/OL.29.000071 ↗
25. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans10.1364/OE.15.006696 ↗
26. Breast imaging technology: probing physiology and molecular function using optical imaging - applications to breast cancer10.1186/bcr269 ↗
27. Hydrophilic cyanine dye as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization10.1562/0031-8655(2000)072<0392:HCDACA>2.0.CO;2 ↗
28. Nitroimidazole radiopharmaceuticals in hypoxia: part ii cytotoxicity and radiosensitization applications10.2174/1874471011104040379 ↗
29. Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia10.1111/j.1349-7006.2009.01195.x ↗
30. Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite10.1016/0003-9861(88)90166-X ↗
31. Pharmacology and toxicology of sensitizers: mechanism studies10.1016/0360-3016(84)90335-3 ↗
32. Rasey · 1999 · 85
33. 124I-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning10.1007/s00259-003-1322-y ↗
34. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles10.2307/3577276 ↗
35. Cytotoxic properties of a 4-nitroimidazole (NSC 38087), a radiosensitizer of hypoxic cells in vitro10.1038/bjc.1981.155 ↗
36. Further studies on toxic and radiosensitizing properties of ruthenium complexes of 4-nitroimidazoles
37. Targeting tumor hypoxia with 2-nitroimidazole-indocyanine green dye conjugates10.1117/1.JBO.18.6.066009 ↗
38. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia10.1021/bc2004704 ↗
39. Imaging tumor hypoxia by near-infrared fluorescence tomography10.1117/1.3589348 ↗
40. Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia10.1111/j.1349-7006.2009.01195.x ↗
41. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia
42. Synthesis and florescent characteristics of imidazole-indocyanine green conjugates10.1016/j.dyepig.2010.08.008 ↗
43. Effect of hypoxia/reoxygenation on CD73 (ecto-5'-nucleotidase) in mouse microvessel endothelial cell lines10.1016/j.mvr.2006.04.005 ↗
44. Structurally modified indocyanine green dyes. Modification of the polyene linker10.1016/j.dyepig.2013.05.001 ↗
45. Targeting tumor hypoxia: a third generation 2-nitroimidazole–indocyanine dye-conjugate with enhanced fluorescent yield10.1039/C5OB01460C ↗
46. Design of hypoxia-targeting drugs as new cancer chemotherapeutics10.1248/bpb.29.2335 ↗
47. Sigma-Aldrich Chemical Co. data. See http://www.sigmaaldrich.com/catalog/product/aldrich/195650?lang=en®ion=US.
48. Synthesis and biological results of the 99mTc -labeled 4-nitroimidazole for imaging tumor hypoxia10.1016/j.bmcl.2003.11.017 ↗
49. Synthesis and biodistribution of novel 99mTc labeled 4-nitroimidazole dithiocarbamate complexes as potential agents to target tumor hypoxia10.1039/C5MD00042D ↗